- Home
- CDNA vs SA Comparison
CDNA vs SA Comparison
Compare CDNA & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- SA
- Stock Information
- Founded
- CDNA 1998
- SA 1979
- Country
- CDNA United States
- SA Canada
- Employees
- CDNA N/A
- SA N/A
- Industry
- CDNA Medical Specialities
- SA Precious Metals
- Sector
- CDNA Health Care
- SA Basic Materials
- Exchange
- CDNA Nasdaq
- SA Nasdaq
- Market Cap
- CDNA 1.1B
- SA 1.0B
- IPO Year
- CDNA 2014
- SA N/A
- Fundamental
- Price
- CDNA $18.90
- SA $12.49
- Analyst Decision
- CDNA Buy
- SA
- Analyst Count
- CDNA 8
- SA 0
- Target Price
- CDNA $29.43
- SA N/A
- AVG Volume (30 Days)
- CDNA 661.3K
- SA 918.7K
- Earning Date
- CDNA 04-30-2025
- SA 05-12-2025
- Dividend Yield
- CDNA N/A
- SA N/A
- EPS Growth
- CDNA N/A
- SA N/A
- EPS
- CDNA 0.93
- SA N/A
- Revenue
- CDNA $333,785,000.00
- SA N/A
- Revenue This Year
- CDNA $13.33
- SA N/A
- Revenue Next Year
- CDNA $15.07
- SA N/A
- P/E Ratio
- CDNA $20.32
- SA N/A
- Revenue Growth
- CDNA 19.07
- SA N/A
- 52 Week Low
- CDNA $7.42
- SA $9.40
- 52 Week High
- CDNA $34.84
- SA $20.55
- Technical
- Relative Strength Index (RSI)
- CDNA 50.38
- SA 60.41
- Support Level
- CDNA $15.78
- SA $9.40
- Resistance Level
- CDNA $20.13
- SA $12.54
- Average True Range (ATR)
- CDNA 1.37
- SA 0.75
- MACD
- CDNA 0.24
- SA 0.13
- Stochastic Oscillator
- CDNA 71.72
- SA 95.08
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.